Several companies made distribution deals this week, while others received approval for their products. Here are some medtech stories we missed this week but were still worth mentioning. 1. Israel OKs E-Qure’s BST device for chronic wounds E-Qure Corp. announced this week that it received marketing approval for its Bio-electrical Signal Therapy Device (BST Device) from the
Meetings Analytics, a data analytics firm that helps companies implement and improve consolidated meetings management programs, will join ZS, the global sales and marketing firm, to expand ZS’s data and analytics capabilities Founded in 2008 by Kimberly Meyer and Peter Matthews, Meetings Analytics offers business intelligence and analytics, data and compliance management and consulting services
Bio-Rad Laboratories (NYSE:BIO) agreed to pay $3.5 million in legal fees for the team that represented former general counsel, Sanford Wadler, during a whistleblower retaliation lawsuit Wadler brought against his former employer. The company said it plans to cover “reasonable” attorney fees and expert witness fees and costs, according to an order signed by U.S.
Medtronic (NYSE:MDT) yesterday touted data presented at the International Stroke Conference on its Solitaire stent retriever from 4 studies. The Solitaire stent retriever uses a micro-sized catheter to access arteries in the brain, restoring blood flow and removing blood clots that cause acute ischemic stroke. The Stratis AIS study evaluated the impact of treatment delays and
By Stewart Eisenhart, Emergo Group The Russian government has pushed back a deadline for replacing medical device registration licenses issued before 2013 to December 2021 in order to harmonize requirements under the Eurasian Economic Union Agreement. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the
Ronald Boumans, Emergo Final versions of the European Medical Device Regulations (MDR) and In Vitro Diagnostic Regulations (IVDR) have been published, and will come to a formal vote by the European Council on March 7 and by the European Parliament on March 20. Following these votes, the MDR and IVDR are expected to be formally published in late
Fritz Faulhaber passed away on Feb. 6 at the age of 68, surrounded by his loving family. He became president of Micromo Electronics (Clearwater, Fla.) in 1981 and a partner in Fritz Faulhaber (Schönaich, Germany) in 1985. He was actively involved as chairman of the supervisory boards for all subsidiaries of the Faulhaber Group, with
Spinal disorder device developer Wenzel Spine said today it completed its acquisition of OsteoMed’s PrimaLok SP interspinous fusion system and FF facet fixation system. The acquired platform includes a polyaxial interspinous process device and percutaneous facet screw system for minimally invasive surgical treatments for lumbar spinal disorders, Austin, Texas-based Wenzel Spine said. “I am pleased that
Biotronik, a global leader in cardio and endovascular medical technology, has developed an online tool called the ProMRI Configurator that allows physicians to select the right MR-conditional heart monitor, pacing or ICD system for their patients with ease. The ProMRI Configurator is an intuitive, user-friendly tool that allows physicians to select the desired MRI conditions,
Nordson and MedPlast are each acquiring a piece of Vention Medical in the latest M&A deal to transform the medical device contract manufacturing landscape. Nordson (Westlake, Ohio) will pay $705 million in cash to acquire Vention’s advanced technologies division, which has locations in New Hampshire, Tennessee, Ireland, Minneapolis, Massachusetts, California, Colorado and Israel. MedPlast (Tempe,
By Stewart Eisenhart, Emergo Group One third of all medical device companies participating in a recent Emergo industry survey reported sales increases of 10% or more for 2016. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect those
Healthcare companies in the U.S. midwest last year brought in $1.7 billion in investments—an amount that came within $60 million of the all-time record set in 2014, according to the BioEnterprise Midwest Healthcare Growth Capital Report. Medical device companies took in the largest chunk of money, raising $696 million, or 40.3% of the total. But
There has been aggressive momentum on the side of federal medical device anti-corruption enforcers, in particular in the Northeast. Maureen Ruane and Scott McBride, Lowenstein Sandler There are more questions than answers on what a new and unconventional administration in the White House will do in 2017 in many areas, no less so in medical
Several companies released diabetes study results this week, while companies like BioTime closed on their public offerings and Pixium implanted its first bionic eye. Here are medtech stories we missed this week, but were still worth mentioning. 1. Insulet touts glucose control study Insulet Corp. announced the results from its first feasibility study of its Omnipod Horizon hybrid
Brad Perriello, Executive Editor A bill filed this week in the U.S. Senate seeks to streamline FDA inspections of medical device manufacturers by creating a more transparent, risk-based approach applied consistently across the federal watchdog’s regional offices. Sponsored by Sens. Johnny Isakson (R-Ga.) and Michael Bennet (D-Colo.), the bill would direct Health & Human Services Dept.